Pioglitazone

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Quantifying Hepatic Mitochondrial Fluxes in Humans

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Insulin Regulation of Lipolysis and Lipolysis Proteins

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving

HbA1c Variability in Type II Diabetes

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Low-Dose Pioglitazone in Patients With NASH (AIM 2)